This was the stock's fourth consecutive day of losses.
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hosted on MSN1d
Is Abbott Laboratories Stock Underperforming the Nasdaq?Valued at a market cap of $202.6 billion, North Chicago, Illinois-based Abbott Laboratories (ABT) is a global healthcare ...
On Friday, Abbott Laboratories (ABT) stock saw a decline, ending the day at $118.93 which represents a decrease of $-0.02 or -0.02% from the prior close of $118.95. The stock opened at $118.71 and ...
A judge denied a request by Abbott Laboratories (NYSE:ABT) for a new trial after a St. Louis jury awarded a plaintiff $500 ...
Hey Texas Children’s Hospital & Baylor College of Medicine this doctor is putting your Medicaid & Medicare funding at risk.
Piper Sandler analyst Adam Maeder maintained a Buy rating on Abbott Laboratories (ABT – Research Report) today and set a price target of ...
Abbott Laboratories (NYSE:ABT – Get Free Report) saw a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 12,050,000 shares, a ...
Texas Gov. Greg Abbott’s threatens hospitals after doctor’s viral video encourages patients to ignore citizenship status ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback